Kiadis announces U.S. FDA approval of the Abigail Wexner ...
Arthur Lahr, CEO of Kiadis commented, "This is the second IND approved by the U.S. FDA for K-NK cells produced with our PM21 platform, and the second IND approved for K-NK cells based on our ...